Ben Ma Selected Research

Thyroid Neoplasms (Thyroid Cancer)

11/2023	LINC00886 Negatively Regulates Malignancy in Anaplastic Thyroid Cancer.
1/2023	Targeting Tumor Hypoxia Inhibits Aggressive Phenotype of Dedifferentiated Thyroid Cancer.
1/2022	Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
1/2022	Immune Checkpoint Protein Expression Defines the Prognosis of Advanced Thyroid Carcinoma.
12/2021	The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial.
7/2021	Arms-qPCR Improves Detection Sensitivity of Earlier Diagnosis of Papillary Thyroid Cancers With Worse Prognosis Determined by Coexisting BRAF V600E and Tert Promoter Mutations.
1/2021	Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
1/2021	Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion.
1/2021	Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer.
1/2021	Cancer-Associated Fibroblasts Positively Correlate with Dedifferentiation and Aggressiveness of Thyroid Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ben Ma Research Topics

Disease

32	Neoplasms (Cancer) 11/2023 - 01/2006
18	Thyroid Neoplasms (Thyroid Cancer) 11/2023 - 03/2017
17	Papillary Thyroid Cancer 01/2022 - 01/2016
6	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2017
5	Hypertension (High Blood Pressure) 01/2022 - 12/2010
4	Hepatocellular Carcinoma (Hepatoma) 04/2023 - 01/2017
4	Hypoxia (Hypoxemia) 01/2023 - 01/2018
4	Cardiomegaly (Heart Hypertrophy) 10/2020 - 08/2013
4	Hypertrophy 01/2018 - 08/2013
4	Neoplasm Metastasis (Metastasis) 02/2017 - 09/2012
3	Anaplastic Thyroid Carcinoma 01/2023 - 01/2019
3	Inflammation (Inflammations) 04/2022 - 12/2010
3	Thyroiditis 01/2020 - 06/2019
2	Infections 01/2023 - 12/2015
2	Heart Failure 01/2020 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 06/2019 - 03/2015
2	Wounds and Injuries (Trauma) 06/2018 - 01/2006
2	Carcinogenesis 05/2018 - 08/2017
2	Adenoid Cystic Carcinoma (Cylindroma) 11/2013 - 09/2012
2	Insulin Resistance 08/2013 - 05/2013
2	Dysmenorrhea (Menstrual Pain) 12/2008 - 10/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2024
1	Diabetes Complications 02/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Cholangiocarcinoma 01/2023
1	Tongue Neoplasms (Tongue Neoplasm) 01/2023
1	Suppuration 08/2022
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 04/2022
1	Body Weight (Weight, Body) 04/2022
1	Fatty Liver 04/2022
1	Pain (Aches) 01/2022
1	Turcot syndrome 01/2022
1	Death (Near-Death Experience) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021
1	Hand-Foot Syndrome 12/2021
1	medullary Thyroid cancer 12/2021
1	Proteinuria 12/2021
1	Hypertriglyceridemia 12/2021

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2010
11	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2014
5	Messenger RNA (mRNA)IBA 01/2023 - 09/2012
5	prolinedithiocarbamate (PDTC)IBA 01/2022 - 01/2019
4	Long Noncoding RNAIBA 06/2021 - 01/2017
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 11/2013
3	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 05/2013
3	Valosin Containing ProteinIBA 10/2020 - 10/2017
3	Untranslated RNA (Noncoding RNA)IBA 01/2017 - 11/2016
3	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 08/2013 - 12/2010
2	RNA Splicing FactorsIBA 04/2023 - 12/2018
2	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2018
2	AdiponectinIBA 04/2022 - 05/2013
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 10/2017
2	Angiotensin IIIBA 01/2022 - 05/2013
2	B7-H1 AntigenIBA 01/2022 - 01/2019
2	VimentinIBA 01/2021 - 01/2017
2	Adenosine Triphosphatases (ATPase)IBA 10/2020 - 10/2017
2	TOR Serine-Threonine KinasesIBA 04/2020 - 08/2017
2	PlatinumIBA 04/2020 - 08/2015
2	DNA (Deoxyribonucleic Acid)IBA 04/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 09/2019 - 01/2017
2	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2018 - 12/2010
2	myocardinIBA 01/2017 - 01/2017
2	Serum Response FactorIBA 01/2017 - 01/2017
1	Mitochondrial DNA (mtDNA)IBA 02/2024
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2023
1	jasmonic acid (jasmonate)IBA 01/2023
1	selinexorIBA 01/2023
1	AcriflavineIBA 01/2023
1	PhytoalexinsIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	ethyleneIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Terpenes (Terpenoids)IBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 04/2022
1	oil red OIBA 04/2022
1	AdipoRonIBA 04/2022
1	LipidsIBA 04/2022
1	Transcription Factors (Transcription Factor)IBA 04/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	IntegrinsIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	SDMIBA 01/2022
1	pexidartinibIBA 12/2021
1	compound 21IBA 12/2021
1	CholesterolIBA 12/2021
1	anlotinibIBA 12/2021
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 12/2021
1	Tyrosine Kinase InhibitorsIBA 12/2021

Therapy/Procedure

15	Therapeutics 02/2024 - 01/2006
5	Immunotherapy 01/2023 - 10/2019
3	Drug Therapy (Chemotherapy) 01/2023 - 11/2013
3	Radiotherapy 01/2023 - 02/2004
3	Uterine Artery Embolization 10/2016 - 01/2006
2	Neck Dissection (Radical Neck Dissection) 01/2020 - 01/2019
2	Thyroidectomy 01/2018 - 03/2017
1	Punctures 08/2022
1	Terminal Care (Care, Terminal) 01/2022
1	Neoadjuvant Therapy 12/2021